Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/896301e5-b0f4-4abb-a4ad-b6d9249cee70/

ERAS

Erasca Inc
Chart
19.17 USD
Latest Week 2026-07-17
Snapshot 2026-07-19 · 0.6w · Fresh
0.62
OS Score
55.0%
Value
53.0%
Quality
54.0%
Momentum
3/9
F-Score
0.540
QV
Strategy Eligibility
1 of 23 passing
OS Composite
Trending Value
Quality × Value
🏛
Cornerstone Value
🌿
Cornerstone Growth
💎
Deep Value
VC2 Cheapest
📐
EBITDA/EV
Veiled Value
Piotroski Bargains
🔬
Quality Compounders
📈
Consistent Earners
🌱
GARP
🔄
Shareholder Yield
💰
High Yield
🚀
Momentum Leaders
Market Leaders
Tiny Titans
🔍
Small Cap Value
🛡
Low Volatility
🏷
Sector Cheapest
🧠
Capital Allocators
Risk-Adj Momentum
RAM 6.44
V
Value Analysis
Cheapness relative to fundamentals
55.0%ile
P/B
16.9×
FCF Yield
-0.014
SH Yield
-0.039
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
46.00000000
/100 — 1=cheapest
VC2 (Trending Value)
46.00000000
/100
VC3 (Buyback)
47.00000000
/100
Negative FCF yield (-1.4%) — the business is currently cash-consumptive.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
53.0%ile
ROE
-0.704
ROA
-0.601
GPA
-0.007
D/E
0.17
Current
9.52
F-Score
3/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Stability
0.982
lower=better
Accruals
-0.403
lower=better
5yr Consist
No
Conservative balance sheet with D/E of 0.17.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
54.0%ile
6M Return
99.3%
12M Return
1178.0%
12-1 Mom
811.3%
Risk-Adj
6.44
Vol 252d
126.0%
Vol 60d
305.4%
↑ Expanding
Max DD 12M
-53.3%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 811% is very strong — a clear uptrend. Risk-adjusted momentum of 6.44 is excellent — strong returns relative to volatility. Near-term vol (305%) is expanding vs long-term (126%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.62
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
Sector Context
Healthcare · 500 peers
Sector Value %ile
46.9%
Sector Quality %ile
41.9%
P/B z-score
0.50
Sector Avg OS
64.0%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
FBIOP Fortress Biotech Inc Pref Series A 99.0% 98.0% 84.0% 96.0%
IRWD Ironwood Pharmaceuticals Inc 99.0% 92.0% 91.0% 98.0%
NUTX Nutex Health Inc 98.0% 91.0% 98.0% 80.0%
FBIO Fortress Biotech Inc 98.0% 98.0% 84.0% 88.0%
TBPH Theravance Biopharma Inc 98.0% 90.0% 99.0% 84.0%
CGEN Compugen 98.0% 89.0% 96.0% 82.0%
RIGL Rigel Pharmaceuticals Inc 98.0% 90.0% 93.0% 93.0%
MD Mednax Inc 97.0% 85.0% 84.0% 93.0%
Factor Interactions
Volatility Expanding
60-day vol (305%) significantly exceeds 252-day (126%). Near-term risk is elevated.
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
1.5% avg (3 factors)
Quality
C
49.3% avg (6 factors)
Momentum
A
100.0% avg (4 factors)
Risk
F
0.0% avg (1 factors)
Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends7 snapshots
Factor Persistence7 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.620—0
Value %ile0.550—0
Quality %ile0.530—0
Momentum %ile0.540—0
F-Score3.000—7
Confidence0.646—0
Volatility1.260—7
Value Lens2021-07-20 → 2026-07-19
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Price / Book
16.91
FCF Yield
-1.4%
Shareholder Yield
Div + net buyback / mktcap
-3.9%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-70.4%
Return on Assets
-60.1%
Gross Profit / Assets
Novy-Marx GPA
-0.7%
Debt / Equity
0.17
Current Ratio
9.52
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.403
MomentumPrice trend strength over different horizons
6M Return
99.3%
12M Return
1178.0%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
811.3%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
6.44
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Earnings Stability (CV)
Lower = more stable
0.982
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
3
Buyback Yield
-3.9%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
46
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
46
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
47
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity